BUMINATE Side Effects

4644181-3 | Sepsis, White Blood Cell Count Decreased
on Mar 25, 2005 Male patient from , 62 years of age, weighting 167.6 lb, was diagnosed with nephrotic syndrome and was treated with Buminate (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?), white blood cell count decreased. Buminate dosage: 100 Ml; Qd; Intravenous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4643957-6 | Abdominal Pain, Sepsis, White Blood Cell Count Decreased
Patient was taking Buminate (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), sepsis (What is sepsis?), white blood cell count decreased on Mar 25, 2005 from Additional patient health information: Male patient , weighting 130.1 lb, was diagnosed with nephrotic syndrome and. Buminate dosage: 100 Ml; Qd; Intravenous. Patient was hospitalized.

4640094-1 | C-reactive Protein Increased, Chills, Pyrexia, Sepsis, White Blood Cell Count Decreased
Adverse event was reported on Mar 22, 2005 by a Male patient taking Buminate (View Usage) (Dosage: 100 Ml;qd;intravenous) was diagnosed with nephrotic syndrome and. Location: , 62 years of age, weighting 167.6 lb, After Buminate was administered, patient had the following side effects: c-reactive protein increased, chills, pyrexia, sepsis (What is sepsis?), white blood cell count decreased. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4640092-8 | Alanine Aminotransferase Increased, Anaphylactoid Reaction, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Dyspnoea, Gamma-glutamyltransferase Increased, Rash, Syncope, Wheezing
on Mar 18, 2005 Female patient from , 69 years of age, weighting 143.3 lb, was diagnosed with liver disorder and was treated with Buminate (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaphylactoid reaction, aspartate aminotransferase increased, blood bilirubin increased, dyspnoea, gamma-glutamyltransferase increased, rash (What is rash?), syncope, wheezing. Buminate dosage: 15 Ml;once;intravenous. Patient was hospitalized.


4597115-4 | Hepatitis C, Intestinal Polyp
on Feb 10, 2005 Female patient from , 72 years of age, weighting 108.0 lb, was diagnosed with hypoproteinaemia and was treated with Buminate (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?), intestinal polyp. Buminate dosage: 100 Ml; Bid; Ijtravenous. During the same period patient was treated with BOLHEAL (View Bolheal Review and Bolheal Label ).

4558376-0 | Hepatitis C, Indirect Infection Transmission
Patient was taking Buminate (View Usage). After Buminate was administered, patient had the following side effects: hepatitis c (What is hepatitis c?), indirect infection transmission on Jan 06, 2005 from Additional patient health information: Female patient , 72 years of age, weighting 108.0 lb, was diagnosed with hypoproteinaemia and. Buminate dosage: 100 Ml; Bid; Intravenous. During the same period patient was treated with BOLHEAL (View Bolheal Review and Bolheal Label ).